Eva María Trinidad

6PUBLICATIONS
55CO-AUTHORS
Cancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMetabolomic chemistryTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 28, 2025
Cytokine Networks in Triple-Negative Breast Cancer: Mechanisms, Therapeutic Targets, and Emerging Strategies.

María Rosado-Sanz, Nuria Martínez-Alarcón, Adrián Abellán-Soriano

|May 30, 2025
RANK Pathway Inhibition Sensitizes Triple-Negative Breast Cancer to CDK4/6 Inhibitors and Enhances Immune Response.

Inês Gomes, Maria Martelo, Rúben D Vilela

|Mar 07, 2023
RANK is a poor prognosis marker and a therapeutic target in ER-negative postmenopausal breast cancer.

Marina Ciscar, Eva M Trinidad, Gema Perez-Chacon

|Jan 07, 2023
Liquidhope: methylome and genomic profiling from very limited quantities of plasma-derived DNA.

Eva María Trinidad, Enrique Vidal, Esther Coronado

|Dec 11, 2020
Inhibition of RANK signaling in breast cancer induces an anti-tumor immune response orchestrated by CD8+ T cells.

Clara Gómez-Aleza, Bastien Nguyen, Guillermo Yoldi

Pageof 1